EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic variations in IKZF3 , LET7 ‐a2, and CDKN2B‐AS1 : Exploring associations with metabolic syndrome susceptibility and clinical manifestations

Alireza Paniri, Mohammad Mahdi Hosseini, Sadegh Fattahi, Galia Amiribozorgi, Mohsen Asouri, Mansooreh Maadi, Nima Motamed, Farhad Zamani, Haleh Akhavan-Niaki iD

Journal of Clinical Laboratory Analysis · 2024

DOI: 10.1002/jcla.24999 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2024. Verfasst von Alireza Paniri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Department, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran. Hauptthemen laut MEDLINE: Atherosclerosis, Diabetes Mellitus, Metabolic Syndrome, MicroRNAs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Babol University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aim Metabolic syndrome (MetS) increases the risk of atherosclerosis and diabetes, but there are no approved predictive markers. This study assessed the role of specific genetic variations in MetS susceptibility and their impact on clinical manifestations.

Method

In this study, a genotype–phenotype assessment was performed for IKZF3 (rs907091), microRNA‐let‐7a‐2 (rs1143770), and lncRNA‐CDKN2B‐AS1 (rs1333045).

Results

Analyses indicate that while rs907091 and rs1143770 may have potential associations with MetS susceptibility and an increased risk of atherosclerosis and diabetes, there is an observed trend suggesting that the rs1333045 CC genotype may be associated with a decreased risk of MetS. The genotypes and allele frequencies of rs1333045 were significantly different between studied groups (OR = 0.56, 95% CI 0.38–0.81, p = 0.002, and OR = 0.71, 95% CI 0.55–0.92, p = 0.008), with the CC genotype displaying increased levels of HDL. Furthermore, the rs907091 TT genotype was associated with increased triglyceride, cholesterol, and HOMA index in MetS patients. Subjects with the CC genotype for rs1143770 had higher HbA1c and BMI. In silico analyses illustrated that rs907091 C remarkably influences the secondary structure and the target site of a broad spectrum of microRNAs, especially hsa‐miR‐4497. Moreover, rs1333045 creates a binding site for seven different microRNAs.

Conclusion

Further studies on other populations may help confirm these SNPs as useful predictive markers in assessing the MetS risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisDiabetes MellitusMetabolic SyndromeMicroRNAsRNA, Long NoncodingHumansGenetic Predisposition to DiseaseGenotypeIkaros Transcription FactorPolymorphism, Single NucleotideRNA, AntisenseCyclin-Dependent Kinase Inhibitor p15

Stichwörter der Autor:innen

LncRNAsSNPsmetabolic syndromemicroRNAsnon-coding RNAsobesitypolymorphism

Substanzen

Ikaros Transcription FactorMicroRNAsRNA, Long NoncodingRNA, AntisenseCDKN2B protein, humanCyclin-Dependent Kinase Inhibitor p15IKZF3 protein, humanmirnlet7 microRNA, human

Autor:innen und Institutionen

  • Genetics Department, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
  • Zoonoses Research Center, Pasteur Institute of Iran, Amol, Iran.
  • Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
  • Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Department of Social Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.

ORCID-Profile: Haleh Akhavan-Niaki

Förderung

  • Babol University of Medical Sciences

Zitieren

APA

Paniri, A., Hosseini, M. M., Fattahi, S., Amiribozorgi, G., Asouri, M., Maadi, M., Motamed, N., Zamani, F., & Akhavan-Niaki, H. (2024). Genetic variations in IKZF3 , LET7 ‐a2, and CDKN2B‐AS1 : Exploring associations with metabolic syndrome susceptibility and clinical manifestations. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.24999

Vancouver

Paniri A, Hosseini MM, Fattahi S, Amiribozorgi G, Asouri M, Maadi M, et al. Genetic variations in IKZF3 , LET7 ‐a2, and CDKN2B‐AS1 : Exploring associations with metabolic syndrome susceptibility and clinical manifestations. Journal of Clinical Laboratory Analysis. 2024. doi:10.1002/jcla.24999

BibTeX
@article{Paniri2024,
  author = {Paniri, Alireza and Hosseini, Mohammad Mahdi and Fattahi, Sadegh and Amiribozorgi, Galia and Asouri, Mohsen and Maadi, Mansooreh and Motamed, Nima and Zamani, Farhad and Akhavan-Niaki, Haleh},
  title = {Genetic variations in IKZF3 , LET7 ‐a2, and CDKN2B‐AS1 : Exploring associations with metabolic syndrome susceptibility and clinical manifestations},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2024},
  doi = {10.1002/jcla.24999}
}
Kostenlos starten →